Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
X
XBI
State Street SPDR S&P Biotech ETF
136.2
0
USD
+9917.65%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9917.65%
Monthly Change
+5.17%
6 month change
+11.88%
Year Change
+23.67%
Previous Close
1.3
6
Open
136.4
8
Low
136.1
5
High
136.7
3
Volume
649
Markets
US ETFs
XBI
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
DNTH
Dianthus Therapeutics Inc
39.5 M
958.9 K
0.5%
BHVN
Biohaven Ltd
39.2 M
3.5 M
0.5%
ARDX
Ardelyx Inc
37.7 M
6.5 M
0.5%
RCUS
Arcus Biosciences Inc
36.7 M
1.5 M
0.5%
NVAX
Novavax Inc
36.7 M
5.5 M
0.5%
TNGX
Tango Therapeutics Inc
33.3 M
3.8 M
0.4%
KURA
Kura Oncology Inc
32.3 M
3.1 M
0.4%
NTLA
Intellia Therapeutics Inc
32.1 M
3.6 M
0.4%
IOVA
Iovance Biotherapeutics Inc
32.0 M
11.7 M
0.4%
TSHA
Taysha Gene Therapies Inc
31.4 M
5.7 M
0.4%
RIGL
Rigel Pharmaceuticals Inc
30.6 M
714.1 K
0.4%
SYRE
Spyre Therapeutics Inc
29.0 M
884.9 K
0.4%
NRIX
Nurix Therapeutics Inc
28.5 M
1.5 M
0.4%
CDNA
CareDx Inc
28.4 M
1.5 M
0.4%
ANAB
AnaptysBio Inc
28.4 M
585.1 K
0.4%
KOD
Kodiak Sciences Inc
27.6 M
986.2 K
0.4%
PVLA
Palvella Therapeutics Inc
27.3 M
260.7 K
0.3%
RLAY
Relay Therapeutics Inc
27.2 M
3.2 M
0.3%
PGEN
Precigen Inc
25.9 M
6.2 M
0.3%
XNCR
Xencor Inc
24.8 M
1.6 M
0.3%
1
2
3
4
5
6
7
8
News
First Quarter Earnings: Sharpening Sector Divergence
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Biotech Investors Are Tuning Out the MAHA Chaos
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint
Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone
Broadcom, Google And Caterpillar Lead AI Charge On Must-See List